Broad Institute Of Mit And Harvard

This is the first study in people to test the safety of a new drug called PrP-siRNA for those already showing symptoms of prion disease, a rare and fatal brain condition. Researchers will give a single injection of the drug into the spinal fluid and monitor 30 participants for 24…